10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2024

Filing Information

Form Type	10-Q
Accession Number	`0001628280-24-002813`
Period End Date	20231231
Filing Date	20240201
Fiscal Year	2024
Fiscal Period	Q2
XBRL Instance	cah-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 84 Cash Flow Statement 60 Stockholders Equity 61 Comprehensive Income 28

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.59B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.04B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$11.79B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$11.34B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	83.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$18.45B	USD	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$15.94B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.82B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.36B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	$144.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperation`	$12.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$37.66B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.83B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.45B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.46B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$5.37B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.08B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.04B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.10B	USD	Point-in-time
Total assets	`Assets`	$46.57B	USD	Point-in-time
Total assets	`Assets`	$43.42B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$34.26B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$29.81B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$792.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.19B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$3.06B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.84B	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	$42.00M	USD	Point-in-time
Liabilities related to assets held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$38.29B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.71B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$3.91B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$3.54B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.65B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.20B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2023 and June 30, 2023	`CommonStockValue`	$2.75B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2023 and June 30, 2023	`CommonStockValue`	$2.85B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-534.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-425.00M	USD	Point-in-time
Common shares in treasury, at cost: 83 million shares and 76 million shares at December 31, 2023 and June 30, 2023, respectively	`TreasuryStockValue`	$5.72B	USD	Point-in-time
Common shares in treasury, at cost: 83 million shares and 76 million shares at December 31, 2023 and June 30, 2023, respectively	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	83.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-151.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-155.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-3.45B	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' deficit	`StockholdersEquity`	$-2.85B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$1.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.45B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.49B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$46.57B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.42B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$112.21B	USD	2 Qtrs
Revenue	`Revenues`	$51.47B	USD	1 Quarter
Revenue	`Revenues`	$101.07B	USD	2 Qtrs
Revenue	`Revenues`	$57.45B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$108.59B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$55.60B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$49.81B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$97.80B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.66B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.85B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.61B	USD	2 Qtrs
Gross margin	`GrossProfit`	$3.28B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.48B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.19B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.39B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.28B	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$46.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$28.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$53.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$17.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$142.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$127.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$63.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$71.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-863.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-538.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-710.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$11.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$52.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$180.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$207.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$468.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$482.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$18.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-119.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$18.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$7.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$16.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$5.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$50.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$25.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$22.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$8.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-137.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$464.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-27.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$490.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$104.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-7.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$136.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-8.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$360.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$354.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$353.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$358.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-20.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-130.00M	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.50	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.08	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.45	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.44	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.43	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.44	USD	2 Qtrs
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.50	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.08	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	266.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	247.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	245.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	261.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	246.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	248.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	261.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	266.00M	shares	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.99	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$360.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$354.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$341.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$347.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-863.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-538.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-710.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$57.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$48.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$43.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$59.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$919.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$487.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$2.54B	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.64B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.95B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.45B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$1.03B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$1.06B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$620.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.73B	USD	2 Qtrs
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	$9.00M	USD	2 Qtrs
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$155.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$206.00M	USD	2 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00M	USD	2 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00M	USD	2 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$2.00M	USD	2 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$5.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	2 Qtrs
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	-	USD	2 Qtrs
Proceeds from net investment hedge terminations	`ProceedsFromHedgeInvestingActivities`	$28.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-157.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-168.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$15.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$13.00M	USD	2 Qtrs
Net tax proceeds from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$9.00M	USD	2 Qtrs
Net tax proceeds from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$1.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$271.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$255.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.25B	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$750.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.02B	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.52B	USD	2 Qtrs
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	2 Qtrs
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.00M	USD	2 Qtrs
Net increase/(decrease) in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.06B	USD	2 Qtrs
Net increase/(decrease) in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$548.00M	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.59B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.65B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.04B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.59B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.65B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.04B	USD	Point-in-time

Stockholders Equity 61 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.45B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.49B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	83.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$5.72B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$360.00M	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$354.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$353.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$358.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-20.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-130.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-4.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$10.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-32.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$30.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-4.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$30.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-32.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$10.00M	USD	1 Quarter
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodSharesShareBasedCompensation`	1.00M	shares	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$58.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$57.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$57.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$47.00M	USD	1 Quarter
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.25B	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$750.00M	USD	2 Qtrs
Dividends	`Dividends`	$249.00M	USD	2 Qtrs
Dividends	`Dividends`	$129.00M	USD	1 Quarter
Dividends	`Dividends`	$260.00M	USD	2 Qtrs
Dividends	`Dividends`	$123.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.00M	USD	2 Qtrs
Other	`StockholdersEquityOther`	$-1.00M	USD	2 Qtrs
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.45B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.49B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockCommonShares`	83.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$5.72B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$4.91B	USD	Point-in-time
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$254.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$1.25B	USD	2 Qtrs
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$250.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$759.00M	USD	2 Qtrs
Purchase of noncontrolling interests	`MinorityInterestDecreaseFromRedemptions`	$2.00M	USD	2 Qtrs
Common shares in treasury	`TreasuryStockCommonShares`	83.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockCommonShares`	76.00M	shares	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$360.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$354.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$20.00M	USD	1 Quarter
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$4.00M	USD	1 Quarter
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$10.00M	USD	1 Quarter
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.00M	USD	2 Qtrs
Net unrealized gain on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$1.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-4.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$10.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-32.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$30.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$356.00M	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-100.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$364.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-51.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$2.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-52.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-100.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$363.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$354.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.